A jurisdiction-by-jurisdiction breakdown of research peptide legal status — covering FDA, TGA, MHRA, Health Canada, WADA, and the key distinctions that determine legality.
The Short Answer
In the United States, research peptides are legal to purchase, possess, and use for legitimate scientific research. They are not classified as controlled substances under the Controlled Substances Act.
Four Key Legal Distinctions
Understanding peptide legality requires distinguishing between four separate legal frameworks that often get conflated: FDA drug approval, DEA scheduling, WADA prohibited list status, and state-level regulations.
Legal Status by Jurisdiction
The following table summarizes the legal status of research peptides for research use in major jurisdictions. Status reflects the general framework as of early 2026 and is subject to change.